Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801

Behavioural Brain Research

Volumn 84, Issue 1-2, 1997, Pages 47-55

  Bardgett, Mark E ^a   Jacobs, Pamela S ^a   Jackson, Jamie L ^a   Csernansky, John G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

dopamine; glutamate; grooming; hippocampus; kainic acid; mesolimbic; NMDA; nucleus accumbens; schizophrenia

Indexed keywords

AMPHETAMINE; DIZOCILPINE; KAINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; HIPPOCAMPUS; LIMBIC SYSTEM; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; DEXTROAMPHETAMINE; DIZOCILPINE MALEATE; DOPAMINE UPTAKE INHIBITORS; ENVIRONMENT; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GROOMING; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; KAINIC ACID; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031047497     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(96)00132-5     Document Type: Article

References (69)

1. Abercrombie, E.D., Keefe, K.A., DiFrischia, D.S. and Zigmond, M.J., Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex, J. Neurochem., 52 (1989) 1655-1658.
2. Akbarian, S., Vinuela, A., Kim, J.J., Potkin, S.G., Bunney, W.E. and Jones, E.G., Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in the temporal lobe of schizophrenics implies anomalous cortical development, Arch. Gen. Psychiatry, 50 (1993) 178-187.
3. Andreasen, N.C., Arndt, S., Swayze, V., II, Flaum, M., O'Leary, D., Ehrhardt, J.C. and Yuh, W.T.C., Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging, Science, 266 (1994) 294-298.
4. Arnold, S.E., Hyman, B.T., Van Hoesen, G.W. and Damasio, A.R., Some cytoarchitectural abnormalities of the entorhinal cortex, Arch. Gen. Psychiatry, 48 (1991) 625-632.
5. Bardgett, M.E., Jackson, J.L., Taylor, G.T. and Csernansky, J.G., Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: An animal model of schizophrenia, Behav. Brain. Res., 70 (1995) 153-164.
6. Benes, F.M., Sorensen, I. and Bird, E.D., Reduced neuronal size in posterior hippocampus of schizophrenic patients, Schizophr. Bull., 17 (1991) 597-608.
7. Bogerts, B., Lieberman, J.A., Ashtari, M., Bilder, R.M., Degreef, G., Lerner, G., John, C. and Masiar, S., Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia, Biol. Psychiatry, 33 (1993) 236-246.
8. Brog, J.S., Salyapongse, A., Deutch, A.Y. and Zahm, D.S., The patterns of afferent innervation of the core and shell in the &accumbens& part of the rat ventral striatum: Immunohistochemical detection of retrogradely transported fluoro-gold, J. Comp. Neurol., 338 (1993) 255-278.
9. Burns, L.H., Robbins, T.W. and Everitt, B.J., Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intraaccumbens infusions of D-amphetamine, Behav. Brain. Res., 55 (1993) 167-183.
10. Costall, B. and Naylor, R.J., Mesolimbic and extrapyramidal sites for the mediation of stereotyped behaviour patterns and hyperactivity by amphetamine and apomorphine in the rat, Adv. Behav. Biol., 21 (1977) 47-76.
11. Csernansky, J.G., Glick, S. and Melletin, J., Differential effects of proglumide on mesolimbic and nigostriatal dopamine function, Psychopharmacology, 91 (1987) 440-444.
12. Csernansky, J.G., Kerr, S., Pruthi, R. and Prosser, E.S., Mesolimbic dopamine receptor increases two weeks following hippocampal kindling, Brain Res., 449 (1988) 357-360.
13. Davis, K.L., Kahn, R.S., Ko, G. and Davidson, M., Dopamine in schizophrenia: a review and reconceptualization, Am. J. Psychiatry, 148 (1991) 1474-1486.
14. Devenport, L.D., Devenport, J.A. and Holloway, F.A., Rewardinduced stereotypy: Modulation by the hippocampus, Science, 212 (1981) 1288-1289.
15. Emerich, D.F. and Walsh, T.J., Hyperactivity following intradentate injection of colchicine: A role for dopamine systems in the nucleus accumbens, Pharm. Biochem. Behav., 37 (1990) 149-154.
16. Fass, B., Temporal changes in open-field activity following progressive lesions of entorhinal cotex: Evidence for enhanced recovery, Behav. Neur. Biol., 37 (1983) 108-124.
17. Fuller, T.A., Russchen, F.T. and Price, J.L., Sources of presumptive glutamatergic/aspartergic afferents to the rat ventral striatopallidal region, J. Comp. Neurol., 258 (1987) 317-338.
18. Gass, P., Herdegen, T., Bravo, R. and Kiessling, M., Spatiotemporal induction of immediate early genes in the rat brain after limbic seizures: Effects of NMDA receptor antagonist MK-801, Eur. J. Neurosci., 5 (1993) 933-943.
19. Grace, A.A., Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia, Neuroscience, 41 (1991) 1-24.
20. Groenewegen, H.J., Vermueulen-Van Der Zee, E., Te Kortschot, A. and Witter, M.P., Organization of the projection from the subiculum to the ventral striatum in the rat. A study using anterograde transport of phaseolus vulgaris leucoagglutinin, Neuroscience, 23 (1987) 103-120.
21. Handelmann, G.E. and Olton, D.S., Spatial memory following damage to hippocampal CA3 pyramidal cells with kainic acid: Impairment and recovery with preoperative training, Brain. Res., 217 (1981) 41-58.
22. Hannigan, J.H., Jr., Springer, J.E. and Issacson, R.L., Differentiation of basal ganglia dopaminergic involvement in behavior after hippocampectomy, Brain. Res., 291 (1984) 83-91.
23. Harrison, P.J., McLaughlin, D. and Kerwin, R.W., Decreased hippocampal gene expression of glutamate receptor gene in schizophrenia, Lancet, 337 (1991) 450-452.
24. Hiramatsu, M., Cho, A.K. and Nabeshima, T., Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine, Eur. J. Pharmacol., 166 (1989) 359-366.
25. Imperato, A., Scrocco, M.G., Bacchi, S. and Angelucci, L., NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus, Eur. J. Pharmacol., 187 (1990) 555-556.
26. Jarrard, L.E., Selective hippocampal lesions and behavior: Effects of kainic acid lesions on performance of place and cue tasks, Behav. Neurosci., 97 (1983) 873-889.
27. Javitt, D.C. and Zukin, S.R., Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiatry, 148 (1991) 1301-1308.
28. Jeste, D.V. and Lohr, J.B., Hippocampal pathologic findings in schizophrenia: A morphometric study, Arch. Gen. Psychiatry, 46 (1989) 1019-1024.
29. Kalivas, P.W. and Duffy, P., Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals, J. Neurosci., 13 (1993) 266-275.
30. Kashihara, K., Hamamura, T., Okumura, K. and Otsuki, S., Effect of MK-801 on endogenous dopamine release in vivo, Brain. Res., 528 (1990) 80-82.
31. Kelley, A.E. and Domesick, V.B., The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: An anterograde-and retrograde-horseradish peroxidase study, Neuroscience, 7 (1982) 2321-2335.
32. Kerwin, R.W. and Murray, R.M., A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia, Schizophr. Bull., 7 (1992) 1-12.
33. Kerwin, R.W., Patel, S. and Meldrum, B.S., Quantitative autoradiographic analysis of glutamate binding sites in the hippocam-pal formation in normal and schizophrenic brain, Neuroscience, 39 (1990) 25-32.
34. Kolb, B., Studies on the caudate-putamen and the dorsomedial thalamic nucleus of the rat: Implications for mammalian frontal lobe functions, Physiol. Behav., 18 (1977) 237-244.
35. Lees, G.J. and Leong, W., The non-NMDA glutamate anatagonist NBQX blocks the local hippocampal toxicity of kainic acid, but not the diffuse extrahippocampal damage, Neurosci. Lett., 143 (1992) 39-42.
36. Lees, G.J. and Leong, W., Differential effects of NBQX on distal and local toxicity of glutamate agonists administered intra-hippocampally, Brain Res., 628 (1993) 1-7.
37. Lipska, B.K., Jaskiw, G.E. and Weinberger, D.R., Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia, Neuropsychopharmacology, 9 (1993) 67-75.
38. Lorenzini, C.A., Baldi, E., Bucherelli, C., Giachetti, A. and Tassoni, G., Effects of nucleus basolateralis amygdala neurotoxic lesions on some spontaneous activities in the rat, Physiol. Behav., 50 (1991) 1215-1219.
39. Loscher, W., Annies, R. and Honack, D., The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats, Neurosci. Lett., 128 (1991) 191-194.
40. Mittleman, G., Jones, G.H. and Robbins, T.W., Sensitization of amphetamine-stereotypy reduces plasma corticosterone: Implications for stereotypy as a coping response, Behav. Neur. Biol., 56 (1991) 170-182.
41. Mittleman, G., LeDuc, P.A. and Whishaw, I.Q., The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: An animal analogue of schizophrenia, Behav. Brain. Res., 55 (1993) 253-267.
42. Morari, M, O'Connor, W.T., Ungerstedt, U. and Fuxe, K., N-methyl-D-aspartate differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral striatum of the halothane-anesthesized rat: An in vivo microdialysis study, J. Neurochem., 60 (1993) 1884-1895.
43. Nadler, J.V., Perry, B.W. and Cotman, C., Preferential vulnerability of hippocampus to intraventricular kainic acid. In E.G. McGeer, J.W. Olney and P.L. McGeer (Eds.) Kainic Acid as a Tool in Neurobiology, Raven Press, New York, 1978, pp. 219-237.
44. Nakajima, S., Franck, J.E., Bilkey, D. and Schwartzkroin, P.A., Local circuit synaptic interactions between CA1 pyramidal cells and interneurons in kainate-lesioned hyperexcitable hippocampus, Hippocampus, 1 (1991) 67-78.
45. Nitecka, L., Tremblay, E., Charton, G., Bouillot, J.P., Berger, M.L. and Ben-Ari, Y., Maturation of kainic acid seizure-brain damage syndrome in the rat II: Histopathological sequelae, Neuroscience, 13 (1984) 1073-1094.
46. Norman, R.M.G. and Malla, A.K., Stressful life events and schizophrenia I: A review of the research, Br. J. Psychiatry, 162 (1993) 161-166.
47. Nuechterlein, K.H., Dawson, M.E., Gitlin, M., Ventura, J., Goldstein, M.J., Synder, K.S., Yee, C.M. and Mintz, J., Developmental processes in schizophrenia disorders: Longitudinal studies of vulnerability and stress, Schizophr. Bull., 18 (1992) 387-424.
48. Nyakas, C.S., De Kloet, E.R., Veldhuis, H.D. and Bohus, B., Hippocampal corticosterone receptors and novelty-induced behavioral activity: Effect of kainic acid lesion of the hippocampus, Brain. Res., 288 (1983) 219-228.
49. Ogren, S.O., Florvall, L., Hall, H., Magnusson, O. and Angeby-Moller, K., Neuropharmacological and behavioral properties of remoxipride in the rat, Acta Psychiatr. Scand., 82 (1990) 21-26.
50. Ogren, S.O. and Goldstein, M., Phencyclidine-and dizocilpine-induced hyperlocomotion are differentially mediated, Neuropsychopharmacology, 11 (1994) 167-177.
51. Olney, J.W. and de Gubareff, T., The fate of synaptic receptors in the kainate-lesioned striatum, Brain Res., 140 (1978) 340-343.
52. Olney, J.W. and Farber, N.B., Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity, J. Clin. Psychiatry, 55 (1994) 43-46.
53. Pakkenberg, B., Pronounced reduction of nerve cell number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics, Arch. Gen. Psychiatry, 47 (1990) 1023-1028.
54. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1986,
55. Phillipson, O.T. and Griffiths, A.C., The topographic order of inputs to the nucleus accumbens in the rat, Neuroscience, 2 (1985) 275-296.
56. Pisa, M., Sanberg, P.R. and Fibiger, H.C., Locomotor activity, exploration, and spatial alternation learning in rats with striatal injections of kainic acid, Physiol. Behav., 24 (1980) 11-19.
57. Port, R.L., Sample, J.A. and Seybold, K.S., Partial hippocampal pyramidal cell loss alters behavior in rats: Implications for an animal model of schizophrenia, Brain. Res. Bull., 26 (1991) 993-996.
58. Prosser, E.S., Pruthi, R. and Csernansky, J.G., Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride, Psychopharmacology, 99 (1989) 109-116.
59. Reinstein, D.K., Hannigan, J.H., Jr. and Issacson, R.L., Time course of certain behavioral changes after hippocampal damage and their alteration by dopaminergic intervention into the nucleus accumbens, Pharm. Biochem. Behav., 17 (1982) 193-202.
60. Schwarcz, R. and Coyle, J.T., Striatal lesions with kainic acid: Neurochemical characteristics, Brain Res., 127 (1977) 235-249.
61. Schwob, J.E., Fuller, T., Price, J.L. and Olney, J.W., Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: A histological study, Neuroscience, 5 (1980) 991-1014.
62. Sutula, T., Cavazos, J. and Golarai, G., Alteration of long-lasting structural and functional effects of kainic acid in the hippocampus by brief treatment with phenobarbital, J. Neurosci., 12 (1991) 4173-4187.
63. Tricklebank, M.D., Sihgh, L., Oles, R.J., Preston, C. and Iversen, S.D., The behavioural effects of MK-801: A comparison with antagonists acting non-competitively at the NMDA receptor, Eur. J. Pharmacol., 167 (1989) 127-135.
64. Turner, D.A. and Wheal, H.V., Excitatory synaptic potentials in kainic acid-denervated rat CA1 pyramidal neurons, J. Neurosci., 11 (1991) 2786-2794.
65. Vecsei, L. and Beal, M.F., Comparative behavioral and neurochemical studies with striatal kainic acid-or quinolinic acid-lesioned rats, Pharm. Biochem. Behav., 39 (1991) 473-478.
66. Whishaw, I.Q. and Mittleman, G., Hippocampal modulation of the nucleus accumbens: Behavioral evidence from amphetamine-induced activity profiles, Behav. Neur. Biol., 55 (1991) 289-306.
67. Wilkinson, L.S., Mittleman, G., Torres, E., Humby, T., Hall, F.S. and Robbins, T.W., Enhancement of amphetamine-induced locomotor activity and dopamine release in the nucleus accumbens following excitotoxic lesions of the hippocampus, Behav. Brain. Res., 55 (1993) 143-150.
68. Willins, D.L., Narayanan, S., Wallace, L.J. and Uretsky, N.J., The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801, Pharm. Biochem. Behav., 46 (1993) 881-887.
69. Wozniak, D.F., Olney, J.W., Kettinger, L., Price, M. and Miller, J.P., Behavioral effects of MK-801 in the rat, Psychopharmacology, 101 (1990) 47-56.